$RPRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REPROS THERAPEUTICS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REPROS THERAPEUTICS INC.. Get notifications about new insider transactions in REPROS THERAPEUTICS INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 12.50 | 4,000 | 50,000 | 34,500 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 25.00 | 500 | 12,500 | 30,500 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 22.50 | 500 | 11,250 | 30,000 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 12.50 | 4,000 | 50,000 | 29,500 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 10.00 | 2,000 | 20,000 | 25,500 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 12.50 | 2,000 | 25,000 | 23,500 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 10.00 | 2,000 | 20,000 | 21,500 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 15.00 | 1,500 | 22,500 | 19,500 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 10.00 | 1,000 | 10,000 | 18,000 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 17.50 | 1,000 | 17,500 | 17,000 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 15.00 | 1,000 | 15,000 | 16,000 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 20.00 | 1,000 | 20,000 | 15,000 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 17.50 | 2,000 | 35,000 | 14,000 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 15.00 | 2,000 | 30,000 | 12,000 | |
| Jan 30 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 15.00 | 2,000 | 30,000 | 10,000 | |
| Jan 23 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 25.00 | 500 | 12,500 | 8,000 | |
| Jan 23 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 22.50 | 500 | 11,250 | 7,500 | |
| Jan 11 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 20.00 | 2,000 | 40,000 | 7,000 | |
| Jan 04 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 20.00 | 1,000 | 20,000 | 5,000 | |
| Jan 04 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 17.50 | 1,000 | 17,500 | 4,000 | |
| Jan 04 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 20.00 | 2,000 | 40,000 | 3,000 | |
| Jan 04 2013 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | S | 17.50 | 1,000 | 17,500 | 1,000 | |
| Oct 29 2012 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Option Exercise | M | 4.43 | 3,333 | 14,765 | 0 | |
| Oct 29 2012 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Payment of Exercise | F | 13.83 | 1,068 | 14,770 | 9,359 | 10.4 K to 9.4 K (-10.24 %) |
| Oct 29 2012 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Buy | M | 4.43 | 3,333 | 14,765 | 10,427 | 7.1 K to 10.4 K (+46.98 %) |
| Sep 13 2012 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | M | 14.84 | 1,250 | 18,550 | 0 | |
| Sep 13 2012 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | M | 14.40 | 10,000 | 144,000 | 0 | |
| Sep 13 2012 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Payment of Exercise | F | 15.27 | 10,645 | 162,549 | 3,355 | 14 K to 3.4 K (-76.04 %) |
| Sep 13 2012 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Buy | M | 14.84 | 1,250 | 18,550 | 14,000 | 12.8 K to 14 K (+9.80 %) |
| Sep 13 2012 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Buy | M | 14.40 | 10,000 | 144,000 | 12,750 | 2.8 K to 12.8 K (+363.64 %) |
| Sep 13 2012 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Option Exercise | M | 4.43 | 9,999 | 44,296 | 0 | |
| Sep 13 2012 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Payment of Exercise | F | 15.25 | 2,905 | 44,301 | 7,094 | 10 K to 7.1 K (-29.05 %) |
| Sep 13 2012 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Buy | M | 4.43 | 9,999 | 44,296 | 9,999 | 0 to 10 K |
| Sep 12 2012 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Option Exercise | A | 14.69 | 20,000 | 293,800 | 20,000 | |
| Sep 07 2012 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 14.23 | 50,000 | 711,500 | 50,000 | |
| Jun 14 2012 | RPRX | REPROS THERAPEUTIC ... | Wyllie Michael | Director | Option Exercise | A | 7.88 | 5,000 | 39,400 | 5,000 | |
| Jun 14 2012 | RPRX | REPROS THERAPEUTIC ... | Thompson Jaye | Director | Option Exercise | A | 7.88 | 5,000 | 39,400 | 5,000 | |
| Jun 14 2012 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 7.88 | 5,000 | 39,400 | 5,000 | |
| Jun 14 2012 | RPRX | REPROS THERAPEUTIC ... | FOURCROY JEAN L MD PHD MPH | Director | Option Exercise | A | 7.88 | 5,000 | 39,400 | 5,000 | |
| Jun 14 2012 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | A | 7.88 | 5,000 | 39,400 | 5,000 | |
| May 15 2012 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.38 | 59,500 | 439,283 | 2,862,560 | 2.8 M to 2.9 M (+2.12 %) |
| May 14 2012 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.35 | 25,000 | 158,800 | 2,803,060 | 2.8 M to 2.8 M (+0.90 %) |
| May 14 2012 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.35 | 145,000 | 921,040 | 2,778,060 | 2.6 M to 2.8 M (+5.51 %) |
| May 11 2012 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.82 | 15,000 | 72,300 | 2,633,060 | 2.6 M to 2.6 M (+0.57 %) |
| May 11 2012 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.82 | 310,000 | 1,493,797 | 2,618,060 | 2.3 M to 2.6 M (+13.43 %) |
| Apr 16 2012 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Buy | P | 3.86 | 3,000 | 11,565 | 3,375 | 375 to 3.4 K (+800.00 %) |
| Mar 06 2012 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Buy | P | 3.99 | 5,000 | 19,964 | 55,945 | 50.9 K to 55.9 K (+9.81 %) |
| Jan 03 2012 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 4.82 | 5,644 | 27,204 | 5,644 | |
| Oct 03 2011 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 3.73 | 7,293 | 27,203 | 7,293 | |
| Aug 24 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 30,300 | 227,250 | 2,308,060 | 2.3 M to 2.3 M (+1.33 %) |
| Aug 24 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.00 | 200,000 | 1,000,000 | 2,277,760 | 2.1 M to 2.3 M (+9.63 %) |
| Aug 24 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 95,300 | 714,750 | 2,077,760 | 2 M to 2.1 M (+4.81 %) |
| Aug 24 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.00 | 400,000 | 2,000,000 | 1,982,460 | 1.6 M to 2 M (+25.28 %) |
| Aug 17 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 800 | 6,000 | 1,582,460 | 1.6 M to 1.6 M (+0.05 %) |
| Aug 12 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 3,800 | 28,500 | 1,581,660 | 1.6 M to 1.6 M (+0.24 %) |
| Aug 12 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 100 | 750 | 1,577,860 | 1.6 M to 1.6 M (+0.01 %) |
| Aug 12 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 4,600 | 34,500 | 1,577,760 | 1.6 M to 1.6 M (+0.29 %) |
| Aug 12 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.50 | 15,100 | 113,250 | 1,573,160 | 1.6 M to 1.6 M (+0.97 %) |
| Aug 03 2011 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Financial Off ... | Option Exercise | A | 5.60 | 125,000 | 700,000 | 125,000 | |
| Jun 03 2011 | RPRX | REPROS THERAPEUTIC ... | FOURCROY JEAN L MD PHD MPH | Director | Option Exercise | A | 5.64 | 5,000 | 28,200 | 5,000 | |
| Jun 03 2011 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 5.64 | 5,000 | 28,200 | 5,000 | |
| Jun 03 2011 | RPRX | REPROS THERAPEUTIC ... | Thompson Jaye | Director | Option Exercise | A | 5.64 | 5,000 | 28,200 | 5,000 | |
| Jun 03 2011 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | A | 5.64 | 5,000 | 28,200 | 5,000 | |
| Jun 03 2011 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 5.64 | 4,823 | 27,202 | 4,823 | |
| Jun 03 2011 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 5.64 | 100,000 | 564,000 | 100,000 | |
| Jun 03 2011 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Accounting Of ... | Option Exercise | A | 5.64 | 5,000 | 28,200 | 5,000 | |
| Mar 18 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.22 | 60,000 | 313,200 | 1,558,060 | 1.5 M to 1.6 M (+4.01 %) |
| Mar 18 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.19 | 26,500 | 137,535 | 1,498,060 | 1.5 M to 1.5 M (+1.80 %) |
| Mar 17 2011 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 5.35 | 5,085 | 27,205 | 5,085 | |
| Mar 09 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 6.47 | 30,000 | 194,100 | 1,471,560 | 1.4 M to 1.5 M (+2.08 %) |
| Mar 02 2011 | RPRX | REPROS THERAPEUTIC ... | Wiehle Ronald | Vice President, R&D | Option Exercise | A | 4.50 | 100,000 | 450,000 | 100,000 | |
| Mar 02 2011 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 4.50 | 300,000 | 1,350,000 | 300,000 | |
| Mar 02 2011 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Accounting Of ... | Option Exercise | A | 4.50 | 50,000 | 225,000 | 50,000 | |
| Mar 02 2011 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | A | 4.50 | 40,000 | 180,000 | 40,000 | |
| Mar 02 2011 | RPRX | REPROS THERAPEUTIC ... | FOURCROY JEAN L MD PHD MPH | Director | Option Exercise | A | 4.50 | 40,000 | 180,000 | 40,000 | |
| Mar 02 2011 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 4.50 | 40,000 | 180,000 | 40,000 | |
| Mar 02 2011 | RPRX | REPROS THERAPEUTIC ... | Thompson Jaye | Director | Option Exercise | A | 4.50 | 40,000 | 180,000 | 40,000 | |
| Mar 02 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.62 | 20,000 | 92,400 | 1,441,560 | 1.4 M to 1.4 M (+1.41 %) |
| Mar 02 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.62 | 30,000 | 138,600 | 1,421,560 | 1.4 M to 1.4 M (+2.16 %) |
| Mar 01 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.46 | 88,273 | 393,698 | 1,391,560 | 1.3 M to 1.4 M (+6.77 %) |
| Feb 28 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.49 | 10,000 | 44,900 | 1,303,287 | 1.3 M to 1.3 M (+0.77 %) |
| Feb 28 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.49 | 38,922 | 174,760 | 1,293,287 | 1.3 M to 1.3 M (+3.10 %) |
| Feb 28 2011 | RPRX | REPROS THERAPEUTIC ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.36 | 110,000 | 479,600 | 1,254,365 | 1.1 M to 1.3 M (+9.61 %) |
| Dec 21 2010 | RPRX | REPROS THERAPEUTIC ... | Wiehle Ronald | Vice President, R&D | Option Exercise | A | 1.37 | 5,018 | 6,875 | 5,018 | |
| Dec 21 2010 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 1.37 | 26,478 | 36,275 | 26,478 | |
| Oct 29 2010 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 1.33 | 27,274 | 36,274 | 27,274 | |
| Oct 29 2010 | RPRX | REPROS THERAPEUTIC ... | Wiehle Ronald | Vice President, R&D | Option Exercise | A | 1.33 | 5,169 | 6,875 | 5,169 | |
| Oct 15 2010 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Buy | P | 1.37 | 13,000 | 17,810 | 50,945 | 37.9 K to 50.9 K (+34.26 %) |
| Aug 26 2010 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 0.60 | 60,458 | 36,275 | 60,458 | |
| Aug 26 2010 | RPRX | REPROS THERAPEUTIC ... | Wiehle Ronald | Vice President, R&D | Option Exercise | A | 0.60 | 11,458 | 6,875 | 11,458 | |
| Jul 09 2010 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Buy | P | 0.30 | 5,000 | 1,500 | 11,000 | 6 K to 11 K (+83.33 %) |
| Jul 09 2010 | RPRX | REPROS THERAPEUTIC ... | Wiehle Ronald | Vice President, R&D | Option Exercise | A | 0.34 | 20,220 | 6,875 | 20,220 | |
| Jul 09 2010 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 0.34 | 106,691 | 36,275 | 106,691 | |
| Jun 25 2010 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Buy | P | 0.41 | 5,000 | 2,050 | 6,000 | 1,000 to 6 K (+500.00 %) |
| Jun 23 2010 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Buy | P | 0.45 | 20,000 | 9,010 | 151,781 | 131.8 K to 151.8 K (+15.18 %) |
| Jun 23 2010 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Buy | P | 0.43 | 12,500 | 5,370 | 131,781 | 119.3 K to 131.8 K (+10.48 %) |
| May 19 2010 | RPRX | REPROS THERAPEUTIC ... | Thompson Jaye | Director | Option Exercise | A | 0.70 | 5,000 | 3,500 | 5,000 | |
| May 19 2010 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 0.70 | 5,000 | 3,500 | 5,000 | |
| May 19 2010 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | A | 0.70 | 5,000 | 3,500 | 5,000 | |
| May 19 2010 | RPRX | REPROS THERAPEUTIC ... | FOURCROY JEAN L MD PHD MPH | Director | Option Exercise | A | 0.70 | 5,000 | 3,500 | 5,000 | |
| May 04 2010 | RPRX | REPROS THERAPEUTIC ... | Wiehle Ronald | Vice President, R&D | Option Exercise | A | 0.79 | 17,405 | 13,750 | 17,405 | |
| May 04 2010 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 0.79 | 45,917 | 36,274 | 45,917 | |
| Feb 05 2010 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 0.82 | 7,000 | 5,740 | 7,000 | |
| Feb 05 2010 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 0.82 | 25,000 | 20,500 | 25,000 | |
| Mar 17 2010 | RPRX | REPROS THERAPEUTIC ... | Anderson Katherine | Chief Accounting Of ... | Option Exercise | A | 0.78 | 40,000 | 31,200 | 40,000 | |
| Feb 05 2010 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | A | 0.82 | 25,000 | 20,500 | 25,000 | |
| Feb 05 2010 | RPRX | REPROS THERAPEUTIC ... | FOURCROY JEAN L MD PHD MPH | Director | Option Exercise | A | 0.82 | 25,000 | 20,500 | 25,000 | |
| Feb 05 2010 | RPRX | REPROS THERAPEUTIC ... | Wiehle Ronald | Vice President, R&D | Option Exercise | A | 0.82 | 25,152 | 20,625 | 25,152 | |
| Feb 05 2010 | RPRX | REPROS THERAPEUTIC ... | Wiehle Ronald | Vice President, R&D | Option Exercise | A | 0.73 | 32,962 | 24,062 | 32,962 | |
| Feb 05 2010 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 0.82 | 66,357 | 54,413 | 66,357 | |
| Feb 05 2010 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | President and CEO | Option Exercise | A | 0.73 | 86,961 | 63,482 | 86,961 | |
| Dec 21 2009 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.65 | 76,703 | 50,202 | 2,552,233 | 2.6 M to 2.6 M (-2.92 %) |
| Dec 21 2009 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.68 | 30,000 | 20,280 | 2,628,936 | 2.7 M to 2.6 M (-1.13 %) |
| Dec 21 2009 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.70 | 50,100 | 35,220 | 2,658,936 | 2.7 M to 2.7 M (-1.85 %) |
| Dec 15 2009 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.67 | 181,700 | 121,739 | 2,709,036 | 2.9 M to 2.7 M (-6.29 %) |
| Dec 15 2009 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.70 | 77,900 | 54,452 | 2,890,736 | 3 M to 2.9 M (-2.62 %) |
| Dec 15 2009 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.70 | 126,500 | 88,044 | 2,968,636 | 3.1 M to 3 M (-4.09 %) |
| Dec 02 2009 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.70 | 262,000 | 182,273 | 3,095,136 | 3.4 M to 3.1 M (-7.80 %) |
| Dec 02 2009 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.71 | 131,000 | 92,800 | 3,357,136 | 3.5 M to 3.4 M (-3.76 %) |
| Dec 02 2009 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.71 | 148,000 | 105,480 | 3,488,136 | 3.6 M to 3.5 M (-4.07 %) |
| Nov 23 2009 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.70 | 227,000 | 159,195 | 3,636,136 | 3.9 M to 3.6 M (-5.88 %) |
| Nov 23 2009 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.71 | 215,000 | 151,984 | 3,863,136 | 4.1 M to 3.9 M (-5.27 %) |
| Nov 23 2009 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Sell | S | 0.75 | 214,000 | 160,222 | 4,078,136 | 4.3 M to 4.1 M (-4.99 %) |
| Nov 20 2009 | RPRX | REPROS THERAPEUTIC ... | Thompson Jaye | Director | Option Exercise | A | 0.70 | 40,000 | 28,000 | 40,000 | |
| May 22 2009 | RPRX | REPROS THERAPEUTIC ... | CAIN DANIEL F | Director | Option Exercise | A | 7.13 | 5,000 | 35,650 | 5,000 | |
| May 22 2009 | RPRX | REPROS THERAPEUTIC ... | Lappe Mark | Director | Option Exercise | A | 7.13 | 5,000 | 35,650 | 5,000 | |
| May 22 2009 | RPRX | REPROS THERAPEUTIC ... | REED JOHN C | Director | Option Exercise | A | 7.13 | 5,000 | 35,650 | 5,000 | |
| May 22 2009 | RPRX | REPROS THERAPEUTIC ... | Masterson Nola E | Director | Option Exercise | A | 7.13 | 5,000 | 35,650 | 5,000 | |
| May 22 2009 | RPRX | REPROS THERAPEUTIC ... | FOURCROY JEAN L MD PHD MPH | Director | Option Exercise | A | 7.13 | 5,000 | 35,650 | 5,000 | |
| May 22 2009 | RPRX | REPROS THERAPEUTIC ... | Howell Stephen B. | Director | Option Exercise | A | 7.13 | 40,000 | 285,200 | 40,000 | |
| Apr 16 2009 | RPRX | REPROS THERAPEUTIC ... | van As Andre MD, PhD | Chief Medical Offic ... | Option Exercise | A | 6.47 | 30,000 | 194,100 | 30,000 | |
| Mar 05 2009 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | Chief Executive Off ... | Buy | P | 6.41 | 4,000 | 25,640 | 119,281 | 115.3 K to 119.3 K (+3.47 %) |
| Feb 27 2009 | RPRX | REPROS THERAPEUTIC ... | Lammers Paul | President | Option Exercise | A | 8.80 | 300,000 | 2,640,000 | 300,000 | |
| Feb 20 2009 | RPRX | REPROS THERAPEUTIC ... | PLOTH LOUIS JR | VP & Chief Financia ... | Option Exercise | A | 8.80 | 20,000 | 176,000 | 20,000 | |
| Feb 20 2009 | RPRX | REPROS THERAPEUTIC ... | PODOLSKI JOSEPH | Chief Executive Off ... | Option Exercise | A | 8.80 | 50,000 | 440,000 | 50,000 | |
| Nov 04 2008 | RPRX | REPROS THERAPEUTIC ... | Lappe Mark | Director | Buy | P | 7.76 | 11,300 | 87,688 | 4,292,136 | 4.3 M to 4.3 M (+0.26 %) |
| Nov 19 2008 | RPRX | REPROS THERAPEUTIC ... | Harder Jeffrey R | Director | Buy | P | 9.82 | 100 | 982 | 400 | 300 to 400 (+33.33 %) |
| Nov 19 2008 | RPRX | REPROS THERAPEUTIC ... | Harder Jeffrey R | Director | Buy | P | 9.78 | 300 | 2,934 | 300 | 0 to 300 |
| Nov 04 2008 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Buy | P | 7.76 | 11,300 | 87,688 | 4,292,136 | 4.3 M to 4.3 M (+0.26 %) |
| Oct 30 2008 | RPRX | REPROS THERAPEUTIC ... | Lappe Mark | Director | Buy | P | 6.97 | 24,400 | 170,068 | 4,280,836 | 4.3 M to 4.3 M (+0.57 %) |
| Oct 30 2008 | RPRX | REPROS THERAPEUTIC ... | Lappe Mark | Director | Buy | P | 6.87 | 9,892 | 67,958 | 4,256,436 | 4.2 M to 4.3 M (+0.23 %) |
| Oct 30 2008 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Buy | P | 6.97 | 24,400 | 170,068 | 4,280,836 | 4.3 M to 4.3 M (+0.57 %) |
| Oct 30 2008 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Buy | P | 6.87 | 9,892 | 67,958 | 4,256,436 | 4.2 M to 4.3 M (+0.23 %) |
| Oct 27 2008 | RPRX | REPROS THERAPEUTIC ... | Lappe Mark | Director | Buy | P | 6.85 | 14,825 | 101,551 | 4,246,544 | 4.2 M to 4.2 M (+0.35 %) |
| Oct 27 2008 | RPRX | REPROS THERAPEUTIC ... | Lappe Mark | Director | Buy | P | 6.89 | 30,000 | 206,700 | 4,231,719 | 4.2 M to 4.2 M (+0.71 %) |
| Oct 27 2008 | RPRX | REPROS THERAPEUTIC ... | Lappe Mark | Director | Buy | P | 6.32 | 17,309 | 109,393 | 4,201,719 | 4.2 M to 4.2 M (+0.41 %) |
| Oct 22 2008 | RPRX | REPROS THERAPEUTIC ... | Harder Jeffrey R | Director | Buy | P | 6.46 | 705 | 4,554 | 10,499 | 9.8 K to 10.5 K (+7.20 %) |
| Oct 22 2008 | RPRX | REPROS THERAPEUTIC ... | Harder Jeffrey R | Director | Buy | P | 6.48 | 1,295 | 8,392 | 9,794 | 8.5 K to 9.8 K (+15.24 %) |
| Oct 27 2008 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Buy | P | 6.85 | 14,825 | 101,551 | 4,246,544 | 4.2 M to 4.2 M (+0.35 %) |
| Oct 27 2008 | RPRX | REPROS THERAPEUTIC ... | Efficacy Capital, Ltd. | 10% Owner | Buy | P | 6.89 | 30,000 | 206,700 | 4,231,719 | 4.2 M to 4.2 M (+0.71 %) |